Human Immunology
DisciplineImmunogenetics, Cellular Immunology and Immune Regulation, Clinical Immunology
LanguageEnglish
Edited byAmy Hahn
Publication details
History1980–present
Publisher
FrequencyMonthly
2.7 (2022)
Standard abbreviations
ISO 4Hum. Immunol.
Indexing
CODENHUIMDQ
ISSN0198-8859 (print)
1879-1166 (web)
LCCN80648846
OCLC no.806501374
Links

Human Immunology is a peer-reviewed academic journal published by Elsevier. This journal features original research articles, review articles and brief communications on the subjects of immunogenetics, cellular immunology and immune regulation, and clinical immunology, and is the journal of the American Society for Histocompatibility and Immunogenetics (ASHI).

The 2022 Thomson Reuters Journal Citation Reports impact factor for Human Immunology is 2.7.[1]

Human Immunology was established in 1980, and has published 12 issues per year since 1983.[2] The journal has had four editors-in-chief; Bernard Amos was editor from 1980 to 1996, Nicole Suciu-Foca was editor from 1997 to 2013, Steven Mack was editor from 2014 to 2016, and Amy Hahn has been editor since 2016.

Abstracting and indexing

The journal is abstracted/indexed in:

American Society for Histocompatibility and Immunogenetics

ASHI
American Society for Histocompatibility and Immunogenetics
Formation1972
TypeScientific society
Location
  • 1120 Route 73, Suite 200 Mt. Laurel, NJ 08054
President
Medhat Askar
Websitewww.ashi-hla.org
Formerly called
CRAB (Cooperative Regions Against Bureaucracy)

The American Society for Histocompatibility and Immunogenetics (ASHI) is the professional society that runs the journal of Human Immunology.[3] Founded in 1972, the society has since gathered over 1,000 members from over 33 countries.[4]

ASHI is the first HLA organization established in the world. They are responsible for accrediting HLA typing laboratories internationally to maintain the quality standards for histocompatibility testing between donors and recipients, with UNOS and NMDP utilizing its service to inspect and determine whether laboratories complied to industrial practices.[5] They also published the first CWD (common and well documented) allele list, encouraging researchers to compare genetic differences between populations.[6]

ASHI also sponsors several awards in recognition of accomplishments and contributions to the field of histocompatibility and immunogenetics, including:[7]

ASHI has also collaborated with EFI (European Federation for Immunogenetics), APHIA (Asia Pacific Histocompatibility and Immunogenetics Association), ARSHI (Arabian Society for Histocompatibility and Immunogenetics) to organize an international summer school for professionals focusing on studying the theories and applications of histocompatibility and immunogenetics.[citation needed]

See also

References

  1. ^ "Human Immunology". 2022 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2023.
  2. ^ "Human Immunology". Elsevier. Retrieved 2014-01-03.
  3. ^ "American Society for Histocompatibility & Immunogenetics". NORD (National Organization for Rare Disorders). Retrieved 2020-04-09.
  4. ^ "ASHI History - American Society for Histocompatibility and Immunogenetics". www.ashi-hla.org. Retrieved 2020-04-09.
  5. ^ "Acrobat Accessibility Report" (PDF). optn.transplant.hrsa.gov. Retrieved 2020-04-09.
  6. ^ He, Jun; Li, Yang; Bao, Xiaojing; Qiu, Qiaocheng; Yuan, Xiaoni; Xu, Chao; Shen, Jiehong; Hou, Jianquan (January 2012). "Common and well-documented (CWD) alleles of human leukocyte antigen-A, -B, -C, -DRB1, and -DQB1 loci for the Chinese Han population do not quite correlate with the ASHI CWD alleles". Human Immunology. 73 (1): 61–66. doi:10.1016/j.humimm.2011.06.005. ISSN 1879-1166. PMID 21712058.
  7. ^ "Awards - American Society for Histocompatibility and Immunogenetics". www.ashi-hla.org. Retrieved 2020-04-09.

External links

Categories